SecBot SecBot
144 ·Filed Jun 9, 2026

HRMY

Harmony Biosciences Holdings, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed5mo ago SEC0001950047-26-005832
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

The proposed sale is small (0.05% of market cap) and by a former officer, not current management. No material negative read-through. Monitor for actual Form 4 filings to confirm execution, but this filing alone does not signal distress or deteriorating fundamentals.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20
Entry
$35.48
T+0 close · Jun 9, 2026 · via day close
Latest settled
+7.69%
T+20 · $38.21
Vs SPY
+4.07%
α at T+20
Next horizon
T+60
due 2mo ago
  1. T+0 · Jun 10 $35.48entry
  2. T+1 · 5mo ago −0.79%α −2.49% · $35.20
  3. T+5 · 5mo ago −4.65%α −8.08% · $33.83
  4. T+20 · 4mo ago +7.69%α +4.07% · $38.21
  5. T+60 · due 2mo ago Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Former officer Sandip Kapadia filed a Form 144 notice of intent to sell up to 27,960 shares (~$943K at recent prices), acquired via cash exercise of options. The sale is routine and proportional relative to the $1.9B market cap, representing a small fraction of typical insider holdings.

Key Facts

  • Sandip Kapadia (former officer) intends to sell 27,960 shares of HRMY common stock.
  • Approximate value ~$943,264 based on filing.
  • Shares acquired via exercise of options under a registered plan on June 5, 2026.
  • Sale intended for June 9, 2026 on Nasdaq.
  • This is intent to sell, not a completed sale.
  • Three prior sales by same insider on 6/4/2026 (7,064 sh), 6/5/2026 (2,101 sh), and 5/8/2026 (45,481 sh) are noted in the filing.

Financial Impact

Up to $943K in potential insider selling, representing ~0.05% of the $1.9B market cap.

dilutioninsider selling

Risk Factors

  • Insider selling could marginally pressure the stock if executed quickly.
  • Former officer selling post-option exercise is routine, but any acceleration beyond this filing would be a concern.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
65% bullish (17 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-005832
Document: 0001950047-26-005832-index.html0001950047-26-005832
Document: 0001950047-26-005832.txt0001950047-26-005832

Track record

20 reports on HRMY

Performance horizon

2 of 3 bullish or bearish reports moved the stock their way by T+20. Best: +14.82% at T+20 after the Jul 16, 2026 report. 4 of 5 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 3/10 Entry $33.21 Now $32.96 −0.75% settles Dec 15
  2. Nov 4, 202612d ago 8-K Bearish 5/10 No price data
  3. Nov 4, 202612d ago Press Release Bearish 5/10 Entry $34.42 Now $32.96 +4.23% settles Dec 3
  4. Nov 2, 202614d ago Institutional Cluster Neutral 3/10 Entry $37.02 Now $32.96 −10.97% settles Dec 2
  5. Oct 30, 202617d ago 8-K/A Neutral 3/10 Entry $37.91 Now $32.96 −13.06% settles Dec 1
  6. Oct 27, 202620d ago SC 13G/A Neutral 2/10 Entry $38.50 Now $32.96 −14.39% settles Nov 25
  7. Oct 13, 20264w ago 8-K Neutral 3/10 Entry $37.03 to $33.55 Now $32.96 −10.99% ▼ −9.40% −5.79% vs SPY
  8. Oct 1, 20266w ago Press Release Neutral 3/10 Entry $39.57 to $38.59 Now $32.96 −16.70% ▼ −2.48% −3.18% vs SPY
  9. Aug 4, 202614w ago 8-K Bullish 7/10 No price data
  10. Aug 4, 202614w ago Press Release Bullish 6/10 Entry $38.78 Now $32.96 −15.01% No price data
Showing 10 of 20

US Market Status

Market Closed · Opens in 7h 58m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 9, 2026